异动解读 | STAAR Surgical股价盘中大跌5.02%,最大股东计划罢免董事反对收购

异动解读
Oct 23

周三盘中,医疗技术公司STAAR Surgical(STAA)股价大跌5.02%,主要原因是公司最大投资者Broadwood Partners计划召开股东大会罢免多名董事,以反对瑞士眼科保健公司爱尔康(Alcon)的收购提议。

据悉,持有STAAR Surgical 27.5%股份的Broadwood Partners强烈反对爱尔康的收购计划。Broadwood Partners创始人兼总裁Neal Bradsher表示,董事会已失去股东信任,需要新的董事来妥善管理公司。除Broadwood Partners外,云启资本(Yunqi Capital)和德丰杰资本(Defender Capital)等投资者也反对这项提议,使反对的股份总计达到已发行股票的近34%。

爱尔康此前提出以每股28美元的价格收购STAAR Surgical,总估值达15亿美元。然而,代理咨询公司机构股东服务公司(ISS)本月早些时候建议STAAR投资者拒绝这一收购提议,理由是最大股东的反对以及与交易相关的"各种缺陷、脱节和不确定性"。值得注意的是,STAAR Surgical近期一直面临收入下降和中国市场销售崩溃的困境。这些因素共同导致了投资者对公司前景的担忧,进而引发了股价的大幅下跌。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10